NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









LinkingMed

LinkingMed

Private
BeijingHealthcare & Life Scienceshttps://linkingmed.com/

Last Round

Series A

Extension

Oct 30, 2019

Total Funding Raised

$15.31M

Company Overview

LinkingMed is an artificial intelligence company that provides a cancer data analysis platform and cloud services for radiotherapy departments and medical centers.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Vertical SaaS, Workflow Automation, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

oncology AIradiotherapy planningmedical imaging AIautomatic contouringradiotherapy softwareOncology Information SystemOISclinical workflow automationradiotherapy quality controlhealthtech AIcloud-based radiotherapyprecision medicinePACS integrationusage-based billing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

LinkingMed Comparables

Compare LinkingMed with similar companies based on industry and business-model similarity.

LinkingMed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Oncosoft
84%
TheraPanacea
83%
MVision AI
78%

LinkingMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionOct 30, 2019
Series AMay 3, 2018
Early FundingJul 5, 2017
AngelDec 15, 2016

LinkingMed Investors

Notable investors and investment history

LinkingMed investors
InvestorRounds
Binhai Venture CapitalSeries A Extension
Guoke Jiahe CapitalAngel
CAS StarAngel
DHVCSeries A
Linear CapitalSeries A, Series A Extension, Early Funding
Anlong FundAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 8, 2025

    Grew 50% QoQ, from 6 to 9 employees.

  • Jan 24, 2025

    Grew 50% QoQ, from 6 to 9 employees.

LinkingMed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

LinkingMed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about LinkingMed's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range10
Year Founded2016
Last FundingOct 30, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.